A Randomized, Open Label, Multinational Phase 3 Trail Co

  • Dudek, Arkadiusz Z (PI)

Project: Research project

Project Details

Description

A Randomized, Open Label, Multinational Phase 3 Trail Comparing Amrubibin Versus Topotecan in Patients with Extensive or Limited and Sensative or Refractory Small Cell Lung Cancer after Failure of First Line Chemotherapy
StatusFinished
Effective start/end date4/1/084/24/12

Funding

  • Celgene Corporation

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.